ArticleHemaSphere2026

Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis.

Barbara Mora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.